STEMCELL2MAX
A novel solution to efficient Haematopoietic Stem Cell regeneration
| Coordinatore | INSTITUTO DE MEDICINA MOLECULAR
Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie. |
| Nazionalità Coordinatore | Portugal [PT] |
| Totale costo | 163˙600 € |
| EC contributo | 149˙885 € |
| Programma | FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | ERC-2013-PoC |
| Funding Scheme | CSA-SA(POC) |
| Anno di inizio | 2014 |
| Periodo (anno-mese-giorno) | 2014-03-01 - 2015-02-28 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
INSTITUTO DE MEDICINA MOLECULAR
Organization address
address: AVENIDA PROF EGAS MONIZ contact info |
PT (LISBOA) | hostInstitution | 149˙885.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'There is an urgent need for improved expansion protocols for haematopoietic stem cells (HSCs). Many studies have tried to stimulate HSC expansion by experimenting with cytokine cocktails in cell culture media. Although these combinations of growth factors are able to increase the amount of HSCs, this happens at the cost of cell maturation: many of the cells in the final culture have lost their 'stemness' and thus their use for treatment and R&D. Dr. Veiga Fernandes has identified crucial survival factors for HSC expansion that increase the stem cell yield 20-fold compared to the current state-of-the-art. This dramatic increase poses serious commercial and societal opportunities. In this ERC PoC project a team of technological and commercial experts will investigate the commercial feasibility of this potentially groundbreaking approach and aims to design the optimal route-to-market with the ultimate goal to attract investors and other strategic partners.'